Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split [Yahoo! Finance]
Pieris Pharmaceuticals, Inc. (PIRS)
NASDAQ:AMEX Investor Relations:
ir.pieris.com
Company Research
Source: Yahoo! Finance
1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's common stock will continue to be traded on The Nasdaq Capital Market on a split-adjusted basis beginning on April 23, 2024, under the Company's existing trading symbol "PIRS". The reverse stock split is intended to regain compliance with the minimum bid price requirement of $1.00 per share of the Company's common stock for continued listing on The Nasdaq Capital Market. The new CUSIP number following the reverse stock split will be 720795202. The Company filed a Certificate of Change with the Nevada Secretary of State on April 18, 2024 to effect the reverse split. The reverse stock split will affect all stockholders uniformly and will not alter the stockholder's percentage ownership interest in the Company, except to the extent that the reverse stock split results in any of the Company's stockholders owning a fractional shar
Show less
Read more
Impact Snapshot
Event Time:
PIRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PIRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PIRS alerts
High impacting Pieris Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
PIRS
News
- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Accesswire
- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
PIRS
Earnings
- 11/14/23 - In-Line
PIRS
Sec Filings
- 4/29/24 - Form 10-K/A
- 4/18/24 - Form 8-K
- 3/29/24 - Form 10-K
- PIRS's page on the SEC website